Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Corrine Quirk"'
Autor:
Chenhui Zou, Imane El Dika, Koen O. A. Vercauteren, Marinela Capanu, Joanne Chou, Jinru Shia, Jill Pilet, Corrine Quirk, Gadi Lalazar, Linda Andrus, Mohammad Kabbani, Amin Yaqubie, Danny Khalil, Taha Mergoub, Luis Chiriboga, Charles M. Rice, Ghassan K. Abou‐Alfa, Ype P. de Jong
Publikováno v:
Cancer Medicine, Vol 11, Iss 3, Pp 602-617 (2022)
Abstract Background Hepatocellular carcinoma (HCC) patient‐derived xenograft (PDX) models hold potential to advance knowledge in HCC biology to help improve systemic therapies. Beside hepatitis B virus‐associated tumors, HCC is poorly established
Externí odkaz:
https://doaj.org/article/94c89770dd5544638da6f30f878a4838
Autor:
Andrew M. Cheung, Elaine Z. Yip, Alison W. Ashbrook, Niluka Goonawardane, Corrine Quirk, Charles M. Rice, Margaret R. MacDonald, Hans-Heinrich Hoffmann
Publikováno v:
Vaccines, Vol 11, Iss 3, p 612 (2023)
Powassan virus (POWV) is an emerging tick-borne virus and cause of lethal encephalitis in humans. The lack of treatment or prevention strategies for POWV disease underscores the need for an effective POWV vaccine. Here, we took two independent approa
Externí odkaz:
https://doaj.org/article/c9877e3cacd14c7f98a32cc80b007701
Autor:
Chenhui Zou, Koen O.A. Vercauteren, Eleftherios Michailidis, Mohammad Kabbani, Irene Zoluthkin, Corrine Quirk, Luis Chiriboga, Mustafa Yazicioglu, Xavier M. Anguela, Philip Meuleman, Katherine A. High, Roland W. Herzog, Ype P. de Jong
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 18, Iss , Pp 189-198 (2020)
Adeno-associated virus (AAV) vector serotypes vary in their ability to transduce hepatocytes from different species. Chimeric mouse models harboring human hepatocytes have shown translational promise for liver-directed gene therapies. However, many v
Externí odkaz:
https://doaj.org/article/76e8a94fb75547cf982881d7ea650537
Autor:
Ursula Andreo, Ype P. de Jong, Margaret A. Scull, Jing W. Xiao, Koen Vercauteren, Corrine Quirk, Michiel C. Mommersteeg, Sonia Bergaya, Arjun Menon, Edward A. Fisher, Charles M. Rice
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 4, Iss 3, Pp 405-417 (2017)
Background & Aims: Hepatitis C virus (HCV) is a leading cause of chronic liver diseases and the most common indication for liver transplantation in the United States. HCV particles in the blood of infected patients are characterized by heterogeneous
Externí odkaz:
https://doaj.org/article/f81b24bdf4364b179d790a21b3bc8ca6
Autor:
Yingpu Yu, William M. Schneider, Maximilian A. Kass, Eleftherios Michailidis, Ashley Acevedo, Ana L. Pamplona Mosimann, Juliano Bordignon, Alexander Koenig, Christine M. Livingston, Hardeep van Gijzel, Yi Ni, Pradeep M. Ambrose, Catherine A. Freije, Mengyin Zhang, Chenhui Zou, Mohammad Kabbani, Corrine Quirk, Cyprien Jahan, Xianfang Wu, Stephan Urban, Shihyun You, Amir Shlomai, Ype P. de Jong, Charles M. Rice
Publikováno v:
Science Advances. 9
Hepatitis B virus (HBV) chronically infects an estimated 300 million people, and standard treatments are rarely curative. Infection increases the risk of liver cirrhosis and hepatocellular carcinoma, and consequently, nearly 1 million people die each
Autor:
Chenhui Zou, Imane El Dika, Koen O. A. Vercauteren, Marinela Capanu, Joanne Chou, Jinru Shia, Jill Pilet, Corrine Quirk, Gadi Lalazar, Linda Andrus, Mohammad Kabbani, Amin Yaqubie, Danny Khalil, Taha Mergoub, Luis Chiriboga, Charles M. Rice, Ghassan K. Abou‐Alfa, Ype P. de Jong
Publikováno v:
Cancer Medicine, Vol 11, Iss 3, Pp 602-617 (2022)
Background Hepatocellular carcinoma (HCC) patient‐derived xenograft (PDX) models hold potential to advance knowledge in HCC biology to help improve systemic therapies. Beside hepatitis B virus‐associated tumors, HCC is poorly established in PDX.
Autor:
Mohammad Kabbani, Philip Meuleman, Eleftherios Michailidis, Ype P. de Jong, Corrine Quirk, Chenhui Zou, Luis Chiriboga, Katherine A. High, Mustafa N. Yazicioglu, Koen Vercauteren, Roland W. Herzog, Xavier M. Anguela, Irene Zoluthkin
Publikováno v:
Molecular Therapy. Methods & Clinical Development
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT
Molecular Therapy: Methods & Clinical Development, Vol 18, Iss, Pp 189-198 (2020)
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT
Molecular Therapy: Methods & Clinical Development, Vol 18, Iss, Pp 189-198 (2020)
Adeno-associated virus (AAV) vector serotypes vary in their ability to transduce hepatocytes from different species. Chimeric mouse models harboring human hepatocytes have shown translational promise for liver-directed gene therapies. However, many v
Autor:
Ype P. de Jong, Charles M. Rice, Corrine Quirk, Helmuth Gehart, Onur Basak, Carmen López-Iglesias, Anne C. Rios, Peter J. Peters, Susana M. Chuva de Sousa Lopes, Chenhui Zou, Jeroen Korving, Johan H. van Es, Benedetta Artegiani, Luis Chiriboga, Harry Begthel, Hans Clevers, Maaike van den Born, Stephanie Ma, Huili Hu, Florijn Dekkers
Publikováno v:
Cell, 175(6), 1591. Cell Press
Cell, 175(6), 1591-1606.e19. Cell Press
Cell, 175(6), 1591-1606.e19. Elsevier B.V.
Cell, 175(6), 1591
Cell, 175(6), 1591-1606.e19. Cell Press
Cell, 175(6), 1591-1606.e19. Elsevier B.V.
Cell, 175(6), 1591
The mammalian liver possesses a remarkable regenerative ability. Two modes of damage response have been described: (1) The “oval cell” response emanates from the biliary tree when all hepatocytes are affected by chronic liver disease. (2) A massi
Autor:
Luis Chiriboga, de Jong Yp, Le Pen J, Gadi Lalazar, Neil D. Theise, Eleftherios Michailidis, Zou C, Briana Zeck, Hiroshi Suemizu, Brandon S. Razooky, Serkan Belkaya, Alison W. Ashbrook, Robert Copenhaver, Ansgar F. Stenzel, Corrine Quirk, Markus Grompe, Sandra Steensels, Lander Foquet, William M. Schneider, Yupu Liang, Inna Ricardo-Lax, Meredith E. Pittman, Devisscher L, Mohanmmad Kabbani, David E. Cohen, Baran A. Ersoy, Clifton G. Fulmer, Charles M. Rice, Tardelli M, Joseph M. Luna, Philip Meuleman
Advanced non-alcoholic fatty liver disease (NAFLD) is a rapidly emerging global health problem associated with pre-disposing genetic polymorphisms, most strikingly an isoleucine to methionine substitution in patatin-like phospholipase domain-containi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd0a146fbea512fa2c6d27aa577929b8
https://doi.org/10.1101/2020.11.19.387613
https://doi.org/10.1101/2020.11.19.387613
Autor:
Chenhui Zou, Brandon S. Razooky, Ype P. de Jong, Lindsey Devisscher, Matteo Tardelli, Hiroshi Suemizu, Mohammad Kabbani, Lander Foquet, William M. Schneider, Meredith E. Pittman, Alison W. Ashbrook, Eleftherios Michailidis, Briana Zeck, Gadi Lalazar, Robert Copenhaver, David E. Cohen, Serkan Belkaya, Inna Ricardo-Lax, Markus Grompe, Luis Chiriboga, Philip Meuleman, Sandra Steensels, Neil D. Theise, Ansgar F. Stenzel, Corrine Quirk, Jérémie Le Pen, Yupu Liang, Charles L. Rice, Joseph M. Luna, Baran A. Ersoy, Clifton G. Fulmer
Publikováno v:
CELL REPORTS
Advanced non-alcoholic fatty liver disease (NAFLD) is a rapidly emerging global health problem associated with pre-disposing genetic polymorphisms, most strikingly an isoleucine to methionine substitution in patatin-like phospholipase domain-containi